Category: NP

Health Canada has contacted the College of Physicians and Surgeons and the CRNS (the “Colleges”) and expressed concern that some Saskatchewan physicians, NPs and RNs are contravening the Food and Drugs Act. It has advised the Colleges that in order to comply with the Food and Drugs Act, a physician or NP must provide a patient specific order (prescription) for each patient to whom an RN will provide an injection of Botox or other bioactive agent.

Click here for the full joint statement.

CRNS Practice and Education Nursing Advisors are available to answer your questions by phone at 1.800.667.9945 or 306.359.4227 or by email at practiceadvice@crns.ca.

The Ministry of Health will be launching the second phase of the Saskatchewan Biosimilars Initiative in February 2026. This phase builds on the progress of the first phase of the Biosimilars Initiative, which was successfully completed in April 2024, and will continue to promote the use of biosimilar medications.

Under the Biosimilars Initiative, patients receive Saskatchewan Drug Plan coverage for a biosimilar version of their biologic medication where one is available and listed on the Saskatchewan Formulary. Biosimilars present a significant opportunity for cost savings and long-term health system sustainability while providing safe and effective medication options. Continued expansion of the Biosimilars Initiative supports patient access to public drug plan coverage.

For more information, visit:

The College of Registered Nurses of Saskatchewan (CRNS) is revising the Prescribing Medication Guideline and the RNs Recommending & Administering Non-prescription Drugs Guideline.

As part of the external consultation process, the CRNS is seeking feedback on both guidelines from registrants and external partners, including the public. Please complete the following surveys by Wednesday, December 4, 2025 at 4 pm.

Prescribing Medication Guideline Survey

RNs Recommending & Administering Non-Prescription Drugs Guideline Survey

Questions or comments are welcome and can be directed to Catharine Wirth at cwirth@crns.ca

The Helicobacter pylori (H. pylori) Clinical Decision Tool (CDT) for RNs with Additional Authorized Practice [RN(AAP)s] has been revised to reflect current evidence-informed practice. The previous H. pylori CDT is no longer in effect. All RN(AAP)s are highly encouraged to review the updated CDT.

The CRNS CDTs are specific evidence-informed documents that guide RN(AAP)s in the assessment, diagnosis, and treatment of limited common medical disorders encountered in primary care settings in Saskatchewan. 

CRNS Practice and Education Nursing Advisors are available to answer your questions by phone at 1.800.667.9945 or 306.359.4227 or by email at practiceadvice@crns.ca.

The Graduate Nurse (GN) Practice Guideline has been reviewed on the five year cycle incorporating both internal and external recommendations, to provide updated direction to employers and registrants in the following areas:

• Bylaw references.
• Language referencing professional conduct.
• Clarification on when a complaint regarding GN practice can be made.
• Content focused on supporting GNs to deliver safe care. 

CRNS Practice and Education Nursing Advisors are available to answer your questions by phone at 1.800.667.9945 or 306.359.4227 or by email at practiceadvice@crns.ca.

The Registered Nurse Specialty Practice (RNSP) Guideline has been revised to provide further clarity in the following areas:

• Roles and responsibilities for employer, authorizer and registrants engaged in self-employed practice; 
• Graphic depicting the RNSP model;
• Enhanced description of the four essential components: client at the centre, supporting evidence, authorizing mechanism and RN competency requirements; and,
• An updated RN Clinical Protocol Checklist that can be utilized during the development, implementation and evaluation of the RNSP. 

CRNS Practice and Education Nursing Advisors are available to answer your questions by phone at 1.800.667.9945 or 306.359.4227 or by email at practiceadvice@crns.ca.